Showing 1 to 2 of 2 results


AI Test Improves Prostate Cancer Treatment Outcomes
A new AI test predicts which men with high-risk prostate cancer will benefit from abiraterone, a drug that halves the risk of death for 25% of patients; this was tested on over 1,000 men and may lead to wider access to the drug.
AI Test Improves Prostate Cancer Treatment Outcomes
A new AI test predicts which men with high-risk prostate cancer will benefit from abiraterone, a drug that halves the risk of death for 25% of patients; this was tested on over 1,000 men and may lead to wider access to the drug.
Progress
48% Bias Score

AI Test Could Slash Prostate Cancer Deaths by Half
A new AI test identifies a biomarker in high-risk prostate cancer patients, enabling targeted abiraterone treatment; reducing the five-year death risk by 47 percent in those with the biomarker, potentially benefiting 2,100 men annually in England.

AI Test Could Slash Prostate Cancer Deaths by Half
A new AI test identifies a biomarker in high-risk prostate cancer patients, enabling targeted abiraterone treatment; reducing the five-year death risk by 47 percent in those with the biomarker, potentially benefiting 2,100 men annually in England.
Progress
48% Bias Score
Showing 1 to 2 of 2 results